BBLG Q3 2021 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$229,789

Net Income

-$509,302

EPS (Diluted)

$-9.96

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$277,770

Free Cash Flow

-$277,770

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$52,393

Total Liabilities

$15M

Stockholders' Equity

-$15M

Cash & Equivalents

$3,374

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$229,789	-$145,823	-57.6%
Net Income	-$509,302	-$394,049	-29.2%